These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20681531)

  • 1. Ingested Shiga toxin 2 (Stx2) causes histopathological changes in kidney, spleen, and thymus tissues and mortality in mice.
    Rasooly R; Do PM; Griffey SM; Vilches-Moure JG; Friedman M
    J Agric Food Chem; 2010 Aug; 58(16):9281-6. PubMed ID: 20681531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7.
    Kim SH; Lee YH; Lee SH; Lee SR; Huh JW; Kim SU; Chang KT
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):427-34. PubMed ID: 22029600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin type 2 (Stx2), a potential agent of bioterrorism, has a short distribution and a long elimination half-life, and induces kidney and thymus lesions in rats.
    Liu YN; Wang SH; Li T; Wang Q; Tu W; Cai K; Hou XJ; Tian RM; Gao X; Liu H; Xiao L; Shi J; Cheng YG; Li JC; Wang H
    Arch Toxicol; 2011 Sep; 85(9):1133-40. PubMed ID: 21279717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
    Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
    Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.
    Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA
    Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
    Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-primed CD11b
    Niu S; Paluszynski J; Bian Z; Shi L; Kidder K; Liu Y
    Sci Rep; 2018 Mar; 8(1):3994. PubMed ID: 29507316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS).
    Mejias MP; Fernandez-Brando RJ; Ramos MV; Abrey-Recalde MJ; Zotta E; Meiss R; Palermo MS
    Curr Pharm Des; 2016; 22(34):5294-5299. PubMed ID: 27356777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production.
    Arimitsu H; Sasaki K; Shimizu T; Tsukamoto K; Shimizu T; Tsuji T
    Microbiol Immunol; 2013 Jan; 57(1):38-45. PubMed ID: 23157558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin Stx2 is heat-stable and not inactivated by pasteurization.
    Rasooly R; Do PM
    Int J Food Microbiol; 2010 Jan; 136(3):290-4. PubMed ID: 19875188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice.
    Zoja C; Locatelli M; Pagani C; Corna D; Zanchi C; Isermann B; Remuzzi G; Conway EM; Noris M
    J Immunol; 2012 Oct; 189(7):3661-8. PubMed ID: 22942429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.
    Flagler MJ; Strasser JE; Chalk CL; Weiss AA
    Infect Immun; 2007 Feb; 75(2):760-5. PubMed ID: 17101648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk.
    He X; McMahon S; Skinner C; Merrill P; Scotcher MC; Stanker LH
    J Immunol Methods; 2013 Mar; 389(1-2):18-28. PubMed ID: 23279946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.
    Fernandez GC; Lopez MF; Gomez SA; Ramos MV; Bentancor LV; Fernandez-Brando RJ; Landoni VI; Dran GI; Meiss R; Isturiz MA; Palermo MS
    Clin Exp Immunol; 2006 Oct; 146(1):76-84. PubMed ID: 16968401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Shiga toxin 2 values in patients during acute phase of diarrhoea-associated haemolytic uraemic syndrome.
    He X; Quiñones B; Loo MT; Loos S; Scavia G; Brigotti M; Levtchenko E; Monnens L
    Acta Paediatr; 2015 Dec; 104(12):e564-8. PubMed ID: 26361237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.
    Creydt VP; Miyakawa MF; Martín F; Zotta E; Silberstein C; Ibarra C
    Braz J Med Biol Res; 2004 Jun; 37(6):799-808. PubMed ID: 15264022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
    Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.